Researchers have developed synthetic peptides that target and inhibit the small, toxic protein aggregates that are thought to trigger Alzheimer’s disease. Neurons in the human brain make a protein called amyloid beta. Such proteins on their own, called monomers of amyloid beta, perform important tasks for neurons. But in the brains of people with Alzheimer’s disease, amyloid beta monomers have abandoned their jobs and joined together. First, they form oligomers – small clumps of up to a dozen proteins – then longer strands and finally large deposits called plaques...

In a proof-of-principle study in mice, scientists at Johns Hopkins Medicine report the creation of a specialized gel that acts like a lymph node to successfully activate and multiply cancer-fighting immune system T-cells. The work puts scientists a step closer, they say, to injecting such artificial lymph nodes into people and sparking T-cells to fight disease.

In the past few years, a wave of discoveries has advanced new techniques to use T-cells – a type of white blood cell – in cancer treatment. To be successful, the cells must be primed, or taught, to spot and react to molecular flags that dot the surfaces of cancer cells...

3D printing of chalcogenide glass could enable low-cost manufacturing of complex optical components for telecom and sensing applications. For the first time, researchers have successfully 3D printed chalcogenide glass, a unique material used to make optical components that operate at mid-infrared wavelengths. The ability to 3D print this glass could make it possible to manufacture complex glass components and optical fibers for new types of low-cost sensors, telecommunications components and biomedical devices.

In The Optical Society (OSA) journal ...